Editorial standards

Primary-source reporting

Every reported development should identify and link to its underlying source. We distinguish agency decisions, trial results, company statements, reporting by other publishers, and public social discussions.

Original value, not automated copying

We intend to collect public metadata and authorized feeds, then publish independently written summaries with relevant context. We do not claim another publisher's reporting as our own or reproduce entire articles without permission.

Claims and scientific uncertainty

We report trial phase, participant counts, study design, conflicts, limitations, and regulatory status where material. Automated content requiring medical or regulatory interpretation will be reviewed before publication.

Sponsored content and conflicts

Advertising partners will not purchase favorable editorial conclusions. Sponsored placements will be clearly labeled. We share common ownership with Driftless Research LLC and will not accept ads from competing peptide sellers.

Corrections

Material errors will be corrected with an explanation of what changed. Our formal correction submission channel will be published before the newsroom opens.